AtriCure Statistics
Total Valuation
AtriCure has a market cap or net worth of $1.76 billion. The enterprise value is $1.70 billion.
Important Dates
The last earnings date was Tuesday, October 29, 2024, after market close.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AtriCure has 48.75 million shares outstanding. The number of shares has increased by 1.35% in one year.
| Current Share Class | 48.75M |
| Shares Outstanding | 48.75M |
| Shares Change (YoY) | +1.35% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 3.40% |
| Owned by Institutions (%) | 104.88% |
| Float | 47.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.77 |
| Forward PS | 3.40 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 10.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 168.93 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.62 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.06 |
Financial Efficiency
Return on equity (ROE) is -8.39% and return on invested capital (ROIC) is -3.96%.
| Return on Equity (ROE) | -8.39% |
| Return on Assets (ROA) | -3.51% |
| Return on Capital (ROIC) | -3.96% |
| Revenue Per Employee | $372,978 |
| Profits Per Employee | -$32,433 |
| Employee Count | 1,200 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, AtriCure has paid $1.13 million in taxes.
| Income Tax | 1.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.18% in the last 52 weeks. The beta is 1.41, so AtriCure's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -13.18% |
| 50-Day Moving Average | 30.62 |
| 200-Day Moving Average | 26.95 |
| Relative Strength Index (RSI) | 62.36 |
| Average Volume (20 Days) | 745,752 |
Short Selling Information
The latest short interest is 2.25 million, so 4.61% of the outstanding shares have been sold short.
| Short Interest | 2.25M |
| Short Previous Month | 3.29M |
| Short % of Shares Out | 4.61% |
| Short % of Float | 4.78% |
| Short Ratio (days to cover) | 3.86 |
Income Statement
In the last 12 months, AtriCure had revenue of $447.57 million and -$38.92 million in losses. Loss per share was -$0.83.
| Revenue | 447.57M |
| Gross Profit | 334.72M |
| Operating Income | -34.16M |
| Pretax Income | -39.27M |
| Net Income | -38.92M |
| EBITDA | -16.07M |
| EBIT | -34.16M |
| Loss Per Share | -$0.83 |
Full Income StatementBalance Sheet
The company has $130.34 million in cash and $77.13 million in debt, giving a net cash position of $53.21 million or $1.09 per share.
| Cash & Cash Equivalents | 130.34M |
| Total Debt | 77.13M |
| Net Cash | 53.21M |
| Net Cash Per Share | $1.09 |
| Equity (Book Value) | 465.02M |
| Book Value Per Share | 9.54 |
| Working Capital | 194.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.40 million and capital expenditures -$11.55 million, giving a free cash flow of -$1.15 million.
| Operating Cash Flow | 10.40M |
| Capital Expenditures | -11.55M |
| Free Cash Flow | -1.15M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 74.79%, with operating and profit margins of -7.63% and -8.70%.
| Gross Margin | 74.79% |
| Operating Margin | -7.63% |
| Pretax Margin | -8.44% |
| Profit Margin | -8.70% |
| EBITDA Margin | -3.59% |
| EBIT Margin | -7.63% |
| FCF Margin | -4.57% |
Dividends & Yields
AtriCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.35% |
| Shareholder Yield | -1.35% |
| Earnings Yield | -2.22% |
| FCF Yield | -0.07% |
Dividend DetailsAnalyst Forecast
The average price target for AtriCure is $43.11, which is 19.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $43.11 |
| Price Target Difference | 19.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 17.07% |
| EPS Growth Forecast (5Y) | -10.24% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AtriCure has an Altman Z-Score of 5.7 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 4 |